HOME >> BIOLOGY >> NEWS
Are bacteria turning our own weapons against us?

Scientists have identified what may be a completely new way in which bacteria defend themselves against their hosts. The bacteria have stolen a key defensive gene from the very animals that they are invading and are now using it against them. This research from the European Molecular Biology Laboratory (EMBL) is featured in today's issue of the open access journal Genome Biology.

EMBL Team Leader Toby Gibson points out that such a discovery has clear medical implications. "This study gives us insight into how infectious bacteria function microbes that cause diseases such as pneumonia, whooping cough and plague are using our own gene against us," he explains. "With this new information, we could potentially produce antibodies to give our immune systems a way to identify the bacteria and block the activity of these weapons."

The gene in question makes a blood protein called alpha-2-macroglobulin, or α2m. This protein and its relatives have been studied in many different animals, and all have a similar function: defending the organism against attacking parasites.

TEPs are α2m-type proteins being studied in the mosquito by EMBL malaria researchers Stephanie Blandin and Elena Levashina. The mosquito is an interesting animal to study such defense proteins its blood-sucking lifestyle brings along a steady stream of invaders. "These α2m-type genes are a strong line of defense they trap molecules that parasites use to attack our cells," notes Blandin. The malaria researchers wanted to learn more about the evolution of TEP, so they enlisted the help of the Gibson team, including PhD student Aidan Budd.

Their findings were completely unexpected.

"During a search for genes similar to TEPs, we were very surprised to discover a bacterial α2m gene - there are no previous reports of such a finding," says Budd.

EMBL Scientists predict that the α2m is used by a bacterium to protect itself from attack
'"/>

Contact: Trista Dawson
dawson@embl.de
49-622-138-7452
European Molecular Biology Laboratory
25-May-2004


Page: 1 2

Related biology news :

1. Researchers find color sensitive atomic switch in bacteria
2. Cancer vaccine based on pathogenic listeria bacteria shows promise targeting metastases
3. Researchers create nanotubes that change colors, form nanocarpet and kill bacteria
4. Scientists discover potential new way to control drug-resistant bacteria
5. 22nd amino acid synthesized and added to genetic code of e. coli bacteria
6. Missing genes may help explain why plague bacteria are so deadly
7. Complex cells likely arose from combination of bacterial and extreme-microbe genomes
8. Stuck on you: Scientists lay bare secrets of bacterial attachment proteins
9. UC Irvine scientists to develop vaccine to combat bioterrorism threat from deadly bacteria
10. UV light, coatings reduce bacterial adhesion up to 50 percent
11. PCB breakdown in rivers depends on sediment-specific bacteria, find Carnegie Mellon U. scientists

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Are bacteria turning our own weapons against

(Date:5/23/2013)... Pacific Northwest National Laboratory honored more than ... of intellectual property at PNNL,s annual Intellectual Property ... The Department of Energy national laboratory named materials ... his work developing battery materials that can store ... electrical grid, and reduce the time it takes ...
(Date:5/23/2013)... 284 million tons of cargo, transit the Panama Canal each ... the Panama Canal Authority. Each time a ship passes through, ... Gatun Lake, which is also a source of water for ... However, the advent of very large "super" cargo ships, now ... demanded change. The Panama Canal is being expanded to create ...
(Date:5/23/2013)... Health at Emory University, along with partners at ... $4 million grant over four years to establish ... Exposome Research Center: Understanding Lifetime Exposures). The grant ... the United States. , The HERCULES Center ... Health Sciences (NIEHS) of the National Institutes of ...
Breaking Biology News(10 mins):PNNL staff recognized for scientific accomplishments, moving technologies into the marketplace 2Reforestation study shows trade-offs between water, carbon and timber 2Reforestation study shows trade-offs between water, carbon and timber 3Emory, Georgia Tech receive first human exposome center grant in US 2Emory, Georgia Tech receive first human exposome center grant in US 3
(Date:5/23/2013)... 2013 Graphite Metallizing Corporation announces ... mounted in stainless steel pillow blocks. This series ... with the application and installation versatility of pillow ... work exceptionally well when submerged in water, ... such as acids, alkalies, hydrocarbons, black liquor, and ...
(Date:5/23/2013)... The maker community is a contemporary group ... focus on learning practical skills while applying them creatively ... their ideas to life via crowdfunding. A subgroup within ... projects using biology. Glowing Plant has worked for months ... glow with bioluminescence genes, and has now pursued crowdfunding ...
(Date:5/23/2013)... Virobay, Inc. today announced that their development ... important milestone, as Virobay has now initiated a Phase ... S inhibitor.   The first Phase 1 ... designed to evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics ... "The initiation of this Phase 1 trial with ...
(Date:5/23/2013)... 23, 2013 Northwest Biotherapeutics (NASDAQ: ... ® personalized immune therapies for solid tumor cancers, ... this year,s American Society Of Clinical Oncology (ASCO) meeting ... leadership role in immune therapy.  (Logo: ... is the pre-eminent conference focused on clinical treatment of ...
Breaking Biology Technology:Graphite Metallizing Now Offers GRAPHALLOY® Stainless Steel Pillow Blocks for Success in Submersible Applications 2Graphite Metallizing Now Offers GRAPHALLOY® Stainless Steel Pillow Blocks for Success in Submersible Applications 3Glowing Plant Releases Maker Kit, Enabling Anyone to Make a Glowing Plant at Home 2Virobay, Inc. initiates a Phase 1 Trial of VBY-036, a compound intended for the treatment of neuropathic pain 2Virobay, Inc. initiates a Phase 1 Trial of VBY-036, a compound intended for the treatment of neuropathic pain 3NW Bio Exhibit at the Upcoming ASCO Meeting to Highlight its Leadership Role in Immune Therapy for Cancer 2NW Bio Exhibit at the Upcoming ASCO Meeting to Highlight its Leadership Role in Immune Therapy for Cancer 3
Cached News: